
--- Page 1 ---
FINAL DIAGNOSIS: PARt 1: LEft SEntinel Lymph nODe #1, BIOpSy -- ONE LYMPH NODE NEGATiVE FOR TUMOR (0/1). Part 2: Left Sentinel Lymph nOde #2, biOpsy -- One Lymph nODe negative fOr tumor (0/1). 1cs-0-3 Curcioma nfItrnHrg ductol, Nos 85Oof3 PaRt 3: Left Sentinel Lymph nODe #3, bIOpSy - ONE LYMPH nODe NEgATIVE fOR TUMOR (0/1) Sit : bresst, Nos c50.9 3131 Part 4: Skin Of Left breast, ExciSiOn - SKIn WITh FIBROSiS. Part 5: Left breast, Segmental mastectomy - A. iNFILTRATING DUCT CARCINQMA 1.0 X 1.0 X 0.9 CM ASSOCIATED WITH MICROCALCIFICATIONS. B. NOt tingham'scORe 6 Out Of 9 (tubules 3, nucleI 2, mItosis 1). C.  NO LYMPHOVASCULAR INVASION IDENTIFIED. D. DUCTAL CARCINOMA IN-SITU, CRIBRIFORM TYPE, NUCLEAR GRADE 2 COMPRISiNG 1% OF INVASIVE TumOR. E.  SURGICAL MARGINS NEGATIVE. F. CLOSEST MARGIN AnTERiOR-0.4 CM. G.  CHANGES CONSISTENT WITH PREVIOUS CORE BiOPSY SITES.E H.  TUMOR IS ESTROGEN RECEPTOR POSITIVE, PROGESTERONE RECEPTOR POSITIVE AND HER-2/NEU  Negative as per core biopsy report. FIBROCYSTIC CHANGES, FIBROADENOMATOID NODULES AND MICROCALCIFICATIONS ASSOCIATED With benign Ducts. J. THERMAL EFFECT. Part 6: Left Breast, new inferiOr margin, resectiOn --  NEgative fOr tumor. Part 7: Left Breast, excision Of fibroadenoma -- A.  FIBROADENOmA. B. CHANGES CONSISTENT WITH PREVIOUS CORE BIOPSY SITE. CASE SYNOPSIS:  SYNOPTIC - PRIMARY INVASIVE CARCINOMA OF BREAST Laterality: PROCEDURE: Left  Segmental LOCATION: SIZE OF TUMOR: Not specified Maximum dimension invasive component: 1.0 cm MULTICENTRICITY/MULTIFOCALITY OF INVASIVE FOCI: TUMOR TYPE (invasive component): No NOTTINGHAm SCORE: Ductal adenocarcinoma, NOS Nuclear grade: 2 UUID:DDAB2FC2-D9F0-4D8F-A7FE-6C0B823E6823 Tubule formation: 3 TCGA-BH-A0BO-01A-PR Redacted Mitotic activity score: 1 Total Nottingham score: 6. ANGIOLYMPHATIC INVASION: Nottingham grade (1, 2, 3): 2 DERMAL LYMPHATIC INVASION: No CALCIFICATION: No Yes, benign zones Tumor type, In SiTu: Yes, malignant zones Cribriform  SURGICAL MARGINS INVOLVED BY INVASIVE COMPONENT:E Percent of tumor occupied by in situ component: 1 % SURG MARGINS INVOLVED BY IN SITU COMPONENT: No LYMPH NODES POSITIVE: No LymPH NODES EXAMINED: 0 METHOD(S) OF LymPH NODE EXAMINATION: 3 SENTINEL NODE METASTASIS: H/E stain, Keratin stain NON-NEOPLASTIC BREAST TISSUE: Fibroadenoma, FCD No t stage, pathologic: N stage, pathologic: pT1b m Stage, pathologic: pNO EStrOgen rECePTOrS: pMX Criterla PROGESTERONE RECEPTORS: positive Diag positive HER2/NEU: zero or 1+ 3/3/r